TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2015

Feasibility and cardiac safety of trastuzumab emtansine after anthracycline-based chemotherapy as (neo)adjuvant therapy for human epidermal growth factor receptor 2-positive early-stage breast cancer.

Ian E Krop et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.